The company in question is, NuVasive, Inc. (NASDAQ:NUVA) currently with a stock price of 65.92 (-0.56% today). The market cap for NuVasive, Inc. is 3321.13, and is in the sector Healthcare, and Medical Appliances & Equipment industry. The target price for NuVasive, Inc. is 70.92. Currently NuVasive, Inc. is trading with a P/E of 68.98, and a forward P/E of 31.87. Average volume for NuVasive, Inc. is 598.64 and so far today it is 104357.
Performance in the last year for NuVasive, Inc. has been 32.42%. For EPS growth, NuVasive, Inc. has seen a growth of 453.30%, and is looking to grow in the next year to 26.21%. More long term stats show that EPS growth has been -6.00% over the last five years and could be 16.06% for the next five years. NuVasive, Inc. has seen sales growth quarter over quarter at 16.40%, with EPS growth quarter over quarter at 186.10%. The 20-day simple moving average is 0.97%, with the 200-day simple moving average coming to 19.70%.
Since the IPO date for NuVasive, Inc. on the 5/13/2004, NuVasive, Inc. has seen performance year to date to be 22.51%. With NuVasive, Inc. trading at 65.92, the dividend yield is *TBA, and the EPS is 0.96.
So could NuVasive, Inc., be undervalued? Well as said before P/E is 68.98. The PEG is 4.3, P/S is 3.83 and the P/B is at 4.73. The P/cash is 10.47, with P/free cash flow at 51.81.
NuVasive, Inc. ability to deal with debt shows that the current ratio is 2.4, and the quick ratio is 1.7. This is with long term debt/equity at 0.79, and total debt/equity at 0.96.
In terms of margins, NuVasive, Inc. has a gross margin of 75.30%, an operating margin of 15.00% and a profit margin of 5.90%.Payout ratio for NuVasive, Inc. is 0.00%. Return on assets come to 3.60% with return on investment coming to 8.50%.
Insider ownership for NuVasive, Inc., is at 0.60% and institutional ownership comes to *TBA. Outstanding shares are at 50.1. While shares float is 49.5. The float short is currently 8.25%, and short ratio is 6.82.